Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


14.08.2017

1 Am J Respir Crit Care Med
1 Ann Surg
6 Ann Thorac Surg
4 Anticancer Res
8 Cancer Lett
1 Cancer Res
1 Clin Lung Cancer
12 Eur J Cancer
1 Eur Respir J
3 J Clin Oncol
1 J Thorac Oncol
1 Lung Cancer
1 Oncol Rep
1 Oncologist
14 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. JOSHI KP, Kaphle U, Steliga MA, Bartter T, et al
    Inflammatory Myo-fibroblastic Tumor of the Lung: A Rare Primary Lung Cancer.
    Am J Respir Crit Care Med. 2017 Aug 10. doi: 10.1164/rccm.201703-0538.
    PubMed     Text format    


    Ann Surg

  2. YANG CJ, Kumar A, Klapper JA, Hartwig MG, et al
    A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer.
    Ann Surg. 2017 Aug 9. doi: 10.1097/SLA.0000000000002342.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  3. HATTORI A, Matsunaga T, Takamochi K, Oh S, et al
    Clinical Significance of Positron Emission Tomography in Subcentimeter Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2017;103:1614-1620.
    PubMed     Text format     Abstract available

  4. VIAL MR, Khan KA, O'Connell O, Peng SA, et al
    Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Nodal Staging of Stereotactic Ablative Body Radiotherapy Patients.
    Ann Thorac Surg. 2016 Dec 24. pii: S0003-4975(16)31375.
    PubMed     Text format     Abstract available

  5. SHIN KW, Cho S, Chung JH, Lee KW, et al
    Comparison of Prognosis of Solid and Part-Solid Node-Negative Adenocarcinoma With the Same Invasive Component Size.
    Ann Thorac Surg. 2017;103:1654-1660.
    PubMed     Text format     Abstract available

  6. ASTUDILLO MG, Dhanasopon AP, Kim AW
    Subacute Pericardial Tamponade After Sleeve Lower Lobectomy for an Extremely Rare Tumor.
    Ann Thorac Surg. 2017;103:e401-e403.
    PubMed     Text format     Abstract available

  7. DUCHATEAU N, Van Bouwel E, Van Schil PE
    Salvage Operation in Case of Oligometastatic Disease.
    Ann Thorac Surg. 2017;103:e409-e411.
    PubMed     Text format     Abstract available

  8. MATSUTANI N, Kanai E, Hanawa R, Takahashi Y, et al
    Pericardial Conduit for Pulmonary Artery Reconstruction by Surgical Stapling.
    Ann Thorac Surg. 2017;103:e469-e471.
    PubMed     Text format     Abstract available


    Anticancer Res

  9. DORE-SAVARD L, Chen Z, Winnard PT Jr, Krishnamachary B, et al
    Delayed Progression of Lung Metastases Following Delivery of a Prodrug-activating Enzyme.
    Anticancer Res. 2017;37:2195-2200.
    PubMed     Text format     Abstract available

  10. MIYATA T, Oyama T, Yoshimatsu T, Higa H, et al
    The Clinical Significance of Cancer Stem Cell Markers ALDH1A1 and CD133 in Lung Adenocarcinoma.
    Anticancer Res. 2017;37:2541-2547.
    PubMed     Text format     Abstract available

  11. JINGU K, Matsuo Y, Onishi H, Yamamoto T, et al
    Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer.
    Anticancer Res. 2017;37:2709-2713.
    PubMed     Text format     Abstract available

  12. AKAMINE T, Toyokawa G, Matsubara T, Kozuma Y, et al
    Significance of the Preoperative CONUT Score in Predicting Postoperative Disease-free and Overall Survival in Patients with Lung Adenocarcinoma with Obstructive Lung Disease.
    Anticancer Res. 2017;37:2735-2742.
    PubMed     Text format     Abstract available


    Cancer Lett

  13. ZYSK A, DeNichilo MO, Panagopoulos V, Zinonos I, et al
    Adoptive transfer of ex vivo expanded Vgamma9Vdelta2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer.
    Cancer Lett. 2016 Nov 16. pii: S0304-3835(16)30699.
    PubMed     Text format     Abstract available

  14. SHEN CJ, Chan SH, Lee CT, Huang WC, et al
    Oleic acid-induced ANGPTL4 enhances head and neck squamous cell carcinoma anoikis resistance and metastasis via up-regulation of fibronectin.
    Cancer Lett. 2017;386:110-122.
    PubMed     Text format     Abstract available

  15. KIM JY, Lee N, Kim YJ, Cho Y, et al
    Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.
    Cancer Lett. 2016 Nov 25. pii: S0304-3835(16)30710.
    PubMed     Text format     Abstract available

  16. CHEN S, Dong Z, Yang P, Wang X, et al
    Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis.
    Cancer Lett. 2017;394:22-32.
    PubMed     Text format     Abstract available

  17. SILVA PM, Ribeiro N, Lima RT, Andrade C, et al
    Suppression of spindly delays mitotic exit and exacerbates cell death response of cancer cells treated with low doses of paclitaxel.
    Cancer Lett. 2017;394:33-42.
    PubMed     Text format     Abstract available

  18. LI J, Tian H, Pan J, Jiang N, et al
    Pecanex functions as a competitive endogenous RNA of S-phase kinase associated protein 2 in lung cancer.
    Cancer Lett. 2017 Aug 5. pii: S0304-3835(17)30466.
    PubMed     Text format     Abstract available

  19. PISANU ME, Noto A, De Vitis C, Morrone S, et al
    Blockade of Stearoyl-CoA-Desaturase 1 activity reverts resistance to Cisplatin in lung cancer stem cells.
    Cancer Lett. 2017 Aug 7. pii: S0304-3835(17)30463.
    PubMed     Text format     Abstract available

  20. PARK KS, Yang H, Choi J, Seo S, et al
    The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer.
    Cancer Lett. 2017 Aug 7. pii: S0304-3835(17)30464.
    PubMed     Text format     Abstract available


    Cancer Res

  21. WALTER DM, Venancio OS, Buza EL, Tobias JW, et al
    Systematic In Vivo Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma.
    Cancer Res. 2017;77:1719-1729.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  22. ZUGAZAGOITIA J, Rueda D, Carrizo N, Enguita AB, et al
    Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non-Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments.
    Clin Lung Cancer. 2017 Jun 23. pii: S1525-7304(17)30181.
    PubMed     Text format     Abstract available


    Eur J Cancer

  23. DE JONGE M, de Weger VA, Dickson MA, Langenberg M, et al
    A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours.
    Eur J Cancer. 2017;76:144-151.
    PubMed     Text format     Abstract available

  24. PALMERINI E, Chawla NS, Ferrari S, Sudan M, et al
    Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
    Eur J Cancer. 2017;76:118-124.
    PubMed     Text format     Abstract available

  25. RAVAUD A, de la Fouchardiere C, Caron P, Doussau A, et al
    A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study.
    Eur J Cancer. 2017;76:110-117.
    PubMed     Text format     Abstract available

  26. ZSCHABITZ S, Lasitschka F, Hadaschik B, Hofheinz RD, et al
    Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation.
    Eur J Cancer. 2017;76:1-7.
    PubMed     Text format     Abstract available

  27. DE BAERE T, Tselikas L, Yevich S, Boige V, et al
    The role of image-guided therapy in the management of colorectal cancer metastatic disease.
    Eur J Cancer. 2017;75:231-242.
    PubMed     Text format     Abstract available

  28. KIM S, Koh J, Kwon D, Keam B, et al
    Comparative analysis of PD-L1 expression between primary and metastatic pulmonary adenocarcinomas.
    Eur J Cancer. 2017;75:141-149.
    PubMed     Text format     Abstract available

  29. SCHAFFAR R, Rachet B, Belot A, Woods LM, et al
    Estimation of net survival for cancer patients: Relative survival setting more robust to some assumption violations than cause-specific setting, a sensitivity analysis on empirical data.
    Eur J Cancer. 2017;72:78-83.
    PubMed     Text format     Abstract available

  30. LEONE JP, Leone J, Zwenger AO, Iturbe J, et al
    Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.
    Eur J Cancer. 2017;74:17-25.
    PubMed     Text format     Abstract available

  31. TWELVES C, Cortes J, O'Shaughnessy J, Awada A, et al
    Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
    Eur J Cancer. 2017;76:205-215.
    PubMed     Text format     Abstract available

  32. FERRY D, Billingham L, Jarrett H, Dunlop D, et al
    Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial.
    Eur J Cancer. 2017;83:302-312.
    PubMed     Text format     Abstract available

  33. CUFARI ME, Proli C, De Sousa P, Raubenheimer H, et al
    Increasing frequency of non-smoking lung cancer: Presentation of patients with early disease to a tertiary institution in the UK.
    Eur J Cancer. 2017;84:55-59.
    PubMed     Text format     Abstract available

  34. SULLIVAN I, Le Teuff G, Guigay J, Caramella C, et al
    Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoids.
    Eur J Cancer. 2017;75:259-267.
    PubMed     Text format     Abstract available


    Eur Respir J

  35. TOMASINI P, Brosseau S, Mazieres J, Merlio JP, et al
    EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    J Clin Oncol

  36. PAGLIARO LC
    Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
    J Clin Oncol. 2017;35:1036-1040.
    PubMed     Text format     Abstract available

  37. NAGTEGAAL ID, Knijn N, Hugen N, Marshall HC, et al
    Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging-A Systematic Review and Meta-Analysis.
    J Clin Oncol. 2016 Dec 28:JCO2016689091.
    PubMed     Text format     Abstract available

  38. SUD A, Thomsen H, Sundquist K, Houlston RS, et al
    Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
    J Clin Oncol. 2017 Mar 13:JCO2016709709. doi: 10.1200/JCO.2016.70.9709.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  39. XIZHAO S, Wei J, Haiqing C, Fan Y, et al
    Validation of the stage groupings in the 8th edition of the TNM classification for lung cancer.
    J Thorac Oncol. 2017 Aug 3. pii: S1556-0864(17)30659.
    PubMed     Text format     Abstract available


    Lung Cancer

  40. LIU E, Guha A, Bertino E, Franco V, et al
    Cardiogenic shock in a patient being treated with atezolizumab for metastatic non-small cell lung cancer.
    Lung Cancer. 2017 Jul 29. pii: S0169-5002(17)30416.
    PubMed     Text format    


    Oncol Rep

  41. TANG T, Huan L, Zhang S, Zhou H, et al
    MicroRNA-212 functions as a tumor-suppressor in human non-small cell lung cancer by targeting SOX4.
    Oncol Rep. 2017 Aug 7. doi: 10.3892/or.2017.5885.
    PubMed     Text format     Abstract available


    Oncologist

  42. STINCHCOMBE TE
    Current Treatments for Surgically Resectable, Limited-Stage, and Extensive-Stage Small Cell Lung Cancer.
    Oncologist. 2017 Aug 4. pii: theoncologist.2017-0204.
    PubMed     Text format     Abstract available


    PLoS One

  43. KISELEVA R, Greineder CF, Villa CH, Hood ED, et al
    Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1.
    PLoS One. 2017;12:e0169537.
    PubMed     Text format     Abstract available

  44. NIKOLOVSKA K, Spillmann D, Haier J, Ladanyi A, et al
    Melanoma Cell Adhesion and Migration Is Modulated by the Uronyl 2-O Sulfotransferase.
    PLoS One. 2017;12:e0170054.
    PubMed     Text format     Abstract available

  45. FANG Y, Zhang C, Wu T, Wang Q, et al
    Transcriptome Sequencing Reveals Key Pathways and Genes Associated with Cisplatin Resistance in Lung Adenocarcinoma A549 Cells.
    PLoS One. 2017;12:e0170609.
    PubMed     Text format     Abstract available

  46. HARATI S, Cooper LA, Moran JD, Giuste FO, et al
    MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development.
    PLoS One. 2017;12:e0170339.
    PubMed     Text format     Abstract available

  47. ORTIZ-ZAPATER E, Lee RW, Owen W, Weitsman G, et al
    MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition.
    PLoS One. 2017;12:e0170798.
    PubMed     Text format     Abstract available

  48. WANICHTHANARAK K, Fan S, Grapov D, Barupal DK, et al
    Metabox: A Toolbox for Metabolomic Data Analysis, Interpretation and Integrative Exploration.
    PLoS One. 2017;12:e0171046.
    PubMed     Text format     Abstract available

  49. KIM EK, Kim KA, Lee CY, Shim HS, et al
    The frequency and clinical impact of HER2 alterations in lung adenocarcinoma.
    PLoS One. 2017;12:e0171280.
    PubMed     Text format     Abstract available

  50. PILYUGIN M, Descloux P, Andre PA, Laszlo V, et al
    BARD1 serum autoantibodies for the detection of lung cancer.
    PLoS One. 2017;12:e0182356.
    PubMed     Text format     Abstract available

  51. NAKANO T, Kanai Y, Amano Y, Yoshimoto T, et al
    Establishment of highly metastatic KRAS mutant lung cancer cell sublines in long-term three-dimensional low attachment cultures.
    PLoS One. 2017;12:e0181342.
    PubMed     Text format     Abstract available

  52. CHENG CC, Chang J, Huang SC, Lin HC, et al
    YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells.
    PLoS One. 2017;12:e0182149.
    PubMed     Text format     Abstract available

  53. CHEN B, Yang L, Zhang R, Gan Y, et al
    Hyperphosphorylation of RPS6KB1, rather than overexpression, predicts worse prognosis in non-small cell lung cancer patients.
    PLoS One. 2017;12:e0182891.
    PubMed     Text format     Abstract available

  54. SCHMIDT LH, Brand C, Stucke-Ring J, Schliemann C, et al
    Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
    PLoS One. 2017;12:e0183201.
    PubMed     Text format     Abstract available

  55. TONG M, Wang J, Jiang N, Pan H, et al
    Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0182282.
    PubMed     Text format     Abstract available

  56. ALSUBAIE N, Trahearn N, Raza SE, Snead D, et al
    Stain Deconvolution Using Statistical Analysis of Multi-Resolution Stain Colour Representation.
    PLoS One. 2017;12:e0169875.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: